Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials

J. I. Silverberg, E. L. Simpson, M. Ardeleanu, D. Thaçi, S. Barbarot, J. Bagel, Z. Chen, L. Eckert, J. Chao, A. Korotzer, E. Rizova, A. B. Rossi, Y. Lu, N. M.H. Graham, T. Hultsch, G. Pirozzi, B. Akinlade

Research output: Contribution to journal › Article › peer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials'. Together they form a unique fingerprint.

Medicine & Life Sciences